Drug Ancillary Supplies Articles & Analysis
10 news found
BOC Sciences, a tech-driven company, is delighted to announce that its team will be participating in the prestigious Drug Discovery Chemistry (DDC) conference in April 2024. The company will be situated at booth #117, showcasing its quality chemical materials and advanced technologies. DDC is an annual event that gathers researchers, scientists, and experts from across the globe who are involved ...
AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany to evaluate ficlatuzumab in combination with ERBITUX® (cetuximab), an EGFR-targeted antibody, in patients with recurrent or metastatic head and neck squamous cell carcinoma ...
Endpoint Clinical, the leader in global interactive response technology (IRT®) for clinical trials, and Berlinger & Co. AG, specializing in the production of innovative and customized solutions for monitoring temperature-sensitive goods in the pharmaceutical and medical industry, have announced their partnership to provide complete end to end visibility of the entire temperature history ...
endpoint Clinical, the leader in global interactive response technology (IRT®) for clinical trials, and THREAD, a leading technology and service provider enabling decentralized clinical trials (DCT), have announced their partnership to offer sponsors and sites a solution that simplifies DCT operations and reduces research study timelines. “Adoption of DCT technologies that are capable ...
Collaboration to focus on establishing supply chain and securing distribution channels for delivering rare disease therapies to patients across China BOSTON, Mass. and SHANGHAI, China, April 19, 2021 – Citrine Medicine, a China-based rare disease therapeutics company, and Sinopharm Group, a Chinese pharmaceutical company, today announced a strategic partnership to accelerate the ...
endpoint Clinical, the leading global interactive response technology (IRT®) company, and McCreadie Group, the market leader in automating manual processes in Investigational Drug Services (IDS), have collaborated to increase study product accountability transparency for study sponsors, reduce site burdens associated with clinical study IMP management, and improve related data integrity via ...
Brentwood is proud to partner with Penn State Health St. Joseph in Berks County’s fight against COVID-19. The company donated 5,000 reusable face shields to the hospital to protect healthcare workers as the pandemic continues. Brentwood President, Peter Rye, and his wife, Leigh, presented the donation to hospital representatives on Wednesday. “We wanted to protect those working to ...
ConsortiEX is proud to announce T3 verification, the newest feature to be added to our DSCSA Compliance as a Service (CaaS) module. The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy. Under the Drug Supply Chain Security Act (DSCSA), health system pharmacies are required to receive, verify, and ...
The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA). The purpose of the guidance was to assist the industry in understanding what requirements need to be met in a variety of situations. The verification requirements apply to manufacturers, wholesale distributors, dispensers and repackagers. The FDA insists ...
Delayed test results often mean HIV patients in Mozambique fail to get timely treatment, but new technology is reducing the need to send tests to far away laboratories, and speeding up test results and HIV treatment. Mozambique's Ministry of Health has increasingly begun experimenting with new technology to make diagnosing and monitoring HIV patients quicker and easier. After a successful 2009 ...